| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |